These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38928416)

  • 1. Downregulation of Protease Cathepsin D and Upregulation of Pathologic α-Synuclein Mediate Paucity of DNAJC6-Induced Degeneration of Dopaminergic Neurons.
    Chiu CC; Chen YL; Weng YH; Liu SY; Li HL; Yeh TH; Wang HL
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of RAB39B Activates ER Stress-Induced Pro-apoptotic Pathway and Causes Mitochondrial Dysfunction and Oxidative Stress in Dopaminergic Neurons by Impairing Autophagy and Upregulating α-Synuclein.
    Chiu CC; Weng YH; Yeh TH; Lu JC; Chen WS; Li AH; Chen YL; Wei KC; Wang HL
    Mol Neurobiol; 2023 May; 60(5):2706-2728. PubMed ID: 36715921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca
    Paillusson S; Gomez-Suaga P; Stoica R; Little D; Gissen P; Devine MJ; Noble W; Hanger DP; Miller CCJ
    Acta Neuropathol; 2017 Jul; 134(1):129-149. PubMed ID: 28337542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.
    Yang SY; Gegg M; Chau D; Schapira A
    Neurobiol Dis; 2020 Feb; 134():104620. PubMed ID: 31634558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.
    Crabtree D; Dodson M; Ouyang X; Boyer-Guittaut M; Liang Q; Ballestas ME; Fineberg N; Zhang J
    J Neurochem; 2014 Mar; 128(6):950-61. PubMed ID: 24138030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
    Rekha KR; Inmozhi Sivakamasundari R
    Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-associated
    Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
    Ho DH; Seol W; Son I
    Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.
    Sevlever D; Jiang P; Yen SH
    Biochemistry; 2008 Sep; 47(36):9678-87. PubMed ID: 18702517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 17. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
    Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
    Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
    Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.